Interstitial lung disease (ILD) and severe ITP

By Fontana Vincenzo   Horstman Lawrence L.   Donna Elio   Dudkiewicz Pamela   Ahn Eugene R.   Ahn Yeon S.  

Hematology, Vol. 12, Iss. 1, 2007-02 ,pp. : 75-80

Maney Publishing

Access to resources Recommend Favorite

Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids

By Tsuchida Tomoko   Matsuse Hiroto   Machida Ikuko   Kondo Yuki   Saeki Sachiko   Tomari Shinya   Obase Yasushi   Matsuo Nobuko   Shimoda Terufumi   Kohno Shigeru  

Allergy and Asthma Proceedings, Vol. 26, Iss. 4, 2005-07 ,pp. : 287-291

OceanSide Publications, Inc

Access to resources Recommend Favorite

Effect of IL-6 on Alveolar Fibroblast Proliferation in Interstitial Lung Diseases

By Shahar I.   Fireman E.   Topilsky M.   Grief J.   Kivity S.   Spirer Z.   Efraim S.B.  

Clinical Immunology, Vol. 79, Iss. 3, 1996-06 ,pp. : 244-251

Academic Press

Access to resources Recommend Favorite

Effect of the Two Different Leukotriene Receptor Antagonists, Montelukast and Zafirlukast, on Quality of Life: A 12-week Randomized Study

By Riccioni Graziano   Vecchia R. Della   Di Ilio C.   D'orazio N.  

Allergy and Asthma Proceedings, Vol. 25, Iss. 6, 2004-11 ,pp. : 445-448

OceanSide Publications, Inc

Access to resources Recommend Favorite

The effect of montelukast on soluble interleukin-2 receptor and tumor necrosis factor α in pediatric asthma

By Can Murat   Yüksel Birol   Demirtaş Selda   Tomaç Nazan  

Allergy and Asthma Proceedings, Vol. 27, Iss. 4, 2006-07 ,pp. : 383-386

OceanSide Publications, Inc

Access to resources Recommend Favorite